TY - JOUR
T1 - Activated partial thromboplastin time and anti-xa measurements in heparin monitoring biochemical basis for discordance
AU - Takemoto, Clifford M.
AU - Streiff, Michael B.
AU - Shermock, Kenneth M.
AU - Kraus, Peggy S.
AU - Chen, Junnan
AU - Jani, Jayesh
AU - Kickler, Thomas
PY - 2013/4
Y1 - 2013/4
N2 - We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin potential (ETP) as a possible measure of anticoagulation. Paired measures of anti-Xa and APTT were performed on 569 samples from 149 patients on UFH. The anti-Xa values and the APTT were concordant in only 54% of measurements. One hundred twelve samples from 59 patients on UFH were assayed for APTT, anti-Xa, factor II, factor VIII, and ETP. Supratherapeutic APTT values but therapeutic anti-Xa results had decreased factor II activity. Subtherapeutic APTT but therapeutic anti-Xa values had high factor VIII activity. ETP correlated with anticoagulation status and UFH dose. In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status.
AB - We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin potential (ETP) as a possible measure of anticoagulation. Paired measures of anti-Xa and APTT were performed on 569 samples from 149 patients on UFH. The anti-Xa values and the APTT were concordant in only 54% of measurements. One hundred twelve samples from 59 patients on UFH were assayed for APTT, anti-Xa, factor II, factor VIII, and ETP. Supratherapeutic APTT values but therapeutic anti-Xa results had decreased factor II activity. Subtherapeutic APTT but therapeutic anti-Xa values had high factor VIII activity. ETP correlated with anticoagulation status and UFH dose. In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status.
KW - Anti-Xa levels
KW - Endogenous thrombin potential
KW - Heparin monitoring
UR - http://www.scopus.com/inward/record.url?scp=84877249391&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877249391&partnerID=8YFLogxK
U2 - 10.1309/AJCPS6OW6DYNOGNH
DO - 10.1309/AJCPS6OW6DYNOGNH
M3 - Article
C2 - 23525615
AN - SCOPUS:84877249391
SN - 0002-9173
VL - 139
SP - 450
EP - 456
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 4
ER -